ROCKET PHARMACEUTICALS Stock Price, News & Analysis
Company Description
ROCKET PHARMACEUTICALS (NASDAQ: RCKTW) is a publicly traded company in the Pharmaceutical Preparations sector.
RCKTW stock has declined 74.2% over the past year. Shares last traded at $0.0099.
On a trailing twelve-month basis, ROCKET PHARMACEUTICALS reported revenue of $0 with net income of -$223.1M and diluted earnings per share of $-2.01.
This page provides a comprehensive overview of RCKTW stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
ROCKET PHARMACEUTICALS (RCKTW) stock last traded at $0.0099, down 1.00% from the previous close. Over the past 12 months, the stock has lost 74.2%.
Latest News
SEC Filings
ROCKET PHARMACEUTICALS has filed 5 recent SEC filings, including 1 Form DEF 14A, 1 Form SCHEDULE 13G/A, 1 Form S-3, 1 Form 8-K. The most recent filing was submitted on April 6, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all RCKTW SEC filings →
Financial Highlights
operating income reached -$231.7M, and net income was -$223.1M. Diluted earnings per share stood at $-2.01. The company generated -$190.0M in operating cash flow. With a current ratio of 6.38, the balance sheet reflects a strong liquidity position.
Upcoming Events
Short Interest History
Short interest in ROCKET PHARMACEUTICALS (RCKTW) currently stands at 2.5 thousand shares, down 67.6% from the previous reporting period. Over the past 12 months, short interest has increased by 459.3%.
Days to Cover History
Days to cover for ROCKET PHARMACEUTICALS (RCKTW) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The ratio has shown significant volatility over the period, ranging from 1.0 to 3.8 days.
RCKTW Company Profile & Sector Positioning
ROCKET PHARMACEUTICALS (RCKTW) operates in the Pharmaceutical Preparations sector and is listed on the NASDAQ.